BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24236747)

  • 21. Biclonal chronic lymphocytic leukemia.
    Hsi ED; Hoeltge G; Tubbs RR
    Am J Clin Pathol; 2000 Jun; 113(6):798-804. PubMed ID: 10874880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.
    Shanafelt TD; Witzig TE; Fink SR; Jenkins RB; Paternoster SF; Smoley SA; Stockero KJ; Nast DM; Flynn HC; Tschumper RC; Geyer S; Zent CS; Call TG; Jelinek DF; Kay NE; Dewald GW
    J Clin Oncol; 2006 Oct; 24(28):4634-41. PubMed ID: 17008705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.
    Travella A; Ripollés L; Aventin A; Rodríguez A; Bezares RF; Caballín MR; Slavutsky I
    Hematol Oncol; 2013 Jun; 31(2):79-87. PubMed ID: 22961973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.
    Sulda ML; Kuss BJ; Hall RK; Bailey S; Macardle PJ
    Intern Med J; 2012 Feb; 42(2):137-46. PubMed ID: 20561095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
    Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
    Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.
    Baliakas P; Iskas M; Gardiner A; Davis Z; Plevova K; Nguyen-Khac F; Malcikova J; Anagnostopoulos A; Glide S; Mould S; Stepanovska K; Brejcha M; Belessi C; Davi F; Pospisilova S; Athanasiadou A; Stamatopoulos K; Oscier D
    Am J Hematol; 2014 Mar; 89(3):249-55. PubMed ID: 24166834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trisomy 12 in B-cell chronic lymphocytic leukemia: interphase study by in situ hybridization in 75 patients.
    Coignet L; Berthéas MF; Vasselon C; Jaubert J; Reynaud J; Calmard-Oriol P; Brizard CP; Guyotat D
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):129-34. PubMed ID: 8332448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
    Aoun P; Zhou G; Chan WC; Page C; Neth K; Pickering D; Sanger W; Quinn-Laquer B; Watson P; Lynch JF; Lynch HT; Weisenburger DD
    Am J Clin Pathol; 2007 Jan; 127(1):31-8. PubMed ID: 17145621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting.
    Chang H; Sutherland R; Nayar R; Li D; Kamel-Reid S; Mile MA; Messner H; Lipton J
    Cancer Genet Cytogenet; 2004 Jul; 152(2):146-8. PubMed ID: 15262435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.
    Huh YO; Abruzzo LV; Rassidakis GZ; Parry-Jones N; Schlette E; Brito-Bapabulle V; Matutes E; Wotherspoon A; Keating MJ; Medeiros LJ; Catovsky D
    Br J Haematol; 2007 Jan; 136(2):220-8. PubMed ID: 17129229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
    Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.
    Alhourani E; Aroutiounian R; Harutyunyan T; Glaser A; Schlie C; Pohle B; Liehr T
    J Histochem Cytochem; 2016 Aug; 64(8):495-501. PubMed ID: 27315825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.
    López C; Delgado J; Costa D; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Cabezas S; Baumann T; Rozman M; Aymerich M; Colomer D; Pereira A; Cobo F; López-Guillermo A; Campo E; Carrió A
    Genes Chromosomes Cancer; 2013 Oct; 52(10):920-7. PubMed ID: 23893575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
    Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
    Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.